Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enno Schmidt

Showing results (81-90 of 348) with videos related to

Pageof 35
Sort By:
JAMA Dermatology|June 23, 2021
Evaluation and Comparison of Clinical and iLaboratory Characteristics of Patients With IgA Epidermolysis Bullosa Acquisita, Linear IgA Bullous Dermatosis, and IgG Epidermolysis Bullosa AcquisitaMareike Becker, Nina Schumacher, Enno Schmidt, et al.
JAMA Dermatology|June 27, 2014
Eczematous reaction to intravenous immunoglobulin: an alternative cause of eczemaJulia Miyamoto, Barbara C Böckle, Detlef Zillikens, et al.
American Journal of Clinical Dermatology|October 7, 2020
More Severe Erosive Phenotype Despite Lower Circulating Autoantibody Levels in Dipeptidyl Peptidase-4 Inhibitor (DPP4i)-Associated Bullous Pemphigoid: A Retrospective Cohort StudySascha Ständer, Enno Schmidt, Detlef Zillikens, et al.
Acta Dermato-Venereologica|August 28, 2020
Remission of Anti-laminin 332 Mucous Membrane Pemphigoid Associated with Non-small Cell Lung Cancer after Therapy with Rituximab and Intravenous ImmunoglobulinEvelyne Tarnowietzki, Thorsten Peters, Lea Kraus, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 2, 2010
Protective endogenous cyclic adenosine 5'-monophosphate signaling triggered by pemphigus autoantibodiesVolker Spindler, Franziska Vielmuth, Enno Schmidt, et al.
Trends in Molecular Medicine|July 9, 2013
Emerging treatments for pemphigoid diseasesRalf J Ludwig, Kathrin Kalies, Jörg Köhl, et al.
The British Journal of Dermatology|August 25, 2025
Anti-p200 pemphigoidMichael Kasperkiewicz, Manuela Pigors, Maike M Holtsche, et al.
Acta Dermato-Venereologica|March 26, 2004
Serum levels of autoantibodies to desmoglein 3 in patients with therapy-resistant pemphigus vulgaris successfully treated with adjuvant intravenous immunoglobulinsSusanne Herzog, Enno Schmidt, Matthias Goebeler, et al.
Der Pathologe|June 17, 2020
[Modern diagnostics of autoimmune bullous diseases]Nina van Beek, Nina Schumacher, Christian Rose, et al.
Frontiers in Medicine|April 18, 2025
Increased risk of skin cancers in mucous membrane pemphigoid: a large-scale matched cohort study of 117 million US individualsAmar Nouri, Henning Olbrich, Enno Schmidt, et al.
Pageof 35

Showing results (81-90 of 348) with videos related to

Sort By:
Pageof 35
JAMA Dermatology|June 23, 2021
Evaluation and Comparison of Clinical and iLaboratory Characteristics of Patients With IgA Epidermolysis Bullosa Acquisita, Linear IgA Bullous Dermatosis, and IgG Epidermolysis Bullosa AcquisitaMareike Becker, Nina Schumacher, Enno Schmidt, et al.
JAMA Dermatology|June 27, 2014
Eczematous reaction to intravenous immunoglobulin: an alternative cause of eczemaJulia Miyamoto, Barbara C Böckle, Detlef Zillikens, et al.
American Journal of Clinical Dermatology|October 7, 2020
More Severe Erosive Phenotype Despite Lower Circulating Autoantibody Levels in Dipeptidyl Peptidase-4 Inhibitor (DPP4i)-Associated Bullous Pemphigoid: A Retrospective Cohort StudySascha Ständer, Enno Schmidt, Detlef Zillikens, et al.
Acta Dermato-Venereologica|August 28, 2020
Remission of Anti-laminin 332 Mucous Membrane Pemphigoid Associated with Non-small Cell Lung Cancer after Therapy with Rituximab and Intravenous ImmunoglobulinEvelyne Tarnowietzki, Thorsten Peters, Lea Kraus, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 2, 2010
Protective endogenous cyclic adenosine 5'-monophosphate signaling triggered by pemphigus autoantibodiesVolker Spindler, Franziska Vielmuth, Enno Schmidt, et al.
Trends in Molecular Medicine|July 9, 2013
Emerging treatments for pemphigoid diseasesRalf J Ludwig, Kathrin Kalies, Jörg Köhl, et al.
The British Journal of Dermatology|August 25, 2025
Anti-p200 pemphigoidMichael Kasperkiewicz, Manuela Pigors, Maike M Holtsche, et al.
Acta Dermato-Venereologica|March 26, 2004
Serum levels of autoantibodies to desmoglein 3 in patients with therapy-resistant pemphigus vulgaris successfully treated with adjuvant intravenous immunoglobulinsSusanne Herzog, Enno Schmidt, Matthias Goebeler, et al.
Der Pathologe|June 17, 2020
[Modern diagnostics of autoimmune bullous diseases]Nina van Beek, Nina Schumacher, Christian Rose, et al.
Frontiers in Medicine|April 18, 2025
Increased risk of skin cancers in mucous membrane pemphigoid: a large-scale matched cohort study of 117 million US individualsAmar Nouri, Henning Olbrich, Enno Schmidt, et al.
Pageof 35